Translational Research: Case of Istanbul University

Slides:



Advertisements
Similar presentations
1 FDA Industry Workshop Statistics in the FDA & Industry The Future David L DeMets, PhD Department of Biostatistics & Medical Informatics University of.
Advertisements

A Vision for Clinical and Translational Research Presentation to the Clinical Research Seminar The University of Oklahoma Health Sciences Center Barbara.
“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH Anantha Shekhar MD, PhD Indiana University School of Medicine Indiana Clinical and.
What is “Biomedical Informatics”?. Biomedical Informatics Biomedical informatics (BMI) is the interdisciplinary field that studies and pursues.
1 The Global Center for Medical Innovation “Accelerating Medical Device Innovation in the Southeast” Southeast Region Technology Transfer Directors Meeting.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
The NIH Roadmap for Medical Research
Working across sectors Building collaborative eco-systems Lars Sundstrom SARTRE.
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Dr Stewart Hay, CEO | | (03) www.therapeuticinnovation.com.au.
The University of North Carolina at Chapel Hill Mary H. Palmer, PhD, RN,C,FAAN Translational Research: Introduction.
Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.
Recognition Of Team Science Faculty Appointments, Promotions and Titles at The Geisel School of Medicine at Dartmouth “Recognition by peers as an investigator.
1 Introduction to Grant Writing Beth Virnig, PhD Haitao Chu, MD, PhD University of Minnesota, School of Public Health December 11, 2013.
UT Southwestern Center for Translational Medicine Summary Statement Discussion November 14, 2013 Robert D. Toto, M.D. Associate Dean for Clinical and Translational.
Research Project Grant (RPG) Retreat K-Series March 2012 Bioengineering Classroom.
Indiana Institute For Personalized Medicine David A Flockhart MD, PhD Professor of Medicine, Genetics and Pharmacology Indiana University.
ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH
Innovation Technology Entrepreneurship Centers (ITECs) Alistair M Brett Senior Consultant, The World Bank Technology Commercialization Advisor, T2 Venture.
AHRQ 2011 Annual Conference: Insights from the AHRQ Peer Review Process Training Grant Review Perspective Denise G. Tate Ph.D., Professor, Chair HCRT Study.
D.Zucker Draft-EB09 Ethics & Academic Technology Transfer: Patients, Products and Public Trust Deborah Zucker, MD, PhD, Tufts Medical Center.
NIH ROADMAP FOR MEDICAL RESEARCH RESEARCH TEAMS OF THE FUTURE.
National Center for Research Resources G. Iris Obrams, M.D., M.P.H., Ph.D. NCRR Update 5 August 2006.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
University of Kentucky Center for Clinical and Translational Science (CCTS) November 2015 Stephen W. Wyatt, DMD, MPH Senior Associate Director Center for.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
1 Center Mission Statements SAMHSA ? CSAT Improving the Health of the Nation by Bringing Effective Alcohol and Drug Treatment to Every Community CMHS Caring.
© UEG Presentation by Towards more coordination in health research: a report on the UEG research symposium 16/11/2012 Michael Manns General Assembly.
Clinical and Translational Science Awards (CTSAs) Future Directions and Opportunities for ACNP investigators.
Nurse Education Practice Quality and Retention- Interprofessional Collaborative Practice: Behavioral Health Integration (NEPQR-IPCP:BHI) Program FY 2016.
NIH R03 Program Review Ning Jackie Zhang, MD, PhD, MPH College of Health and Public Affairs 04/17/2013.
OTC FELLOWS PROGRAM INFORMATION SESSION Fall 2016.
Study Design: Making research pretty Adam P. Sima, PhD July 13, 2016
12/26/2017 From Clinical Trial Research to Reality: Recruitment, Retention, and Community-Engaged Research Sherrie Flynt Wallington, PhD Assistant Professor.
TITIN ANDRI WIHASTUTI SCHOOL OF NURSING FACULTY OF MEDICINE
OUHSC Vision/Initiatives for
Southeast Region Technology Transfer Directors Meeting July 13, 2012
NIHR Invention for Innovation (i4i)
Our Vision Our Purpose What we do Our Strategic Aims
XS2I4MS – Final Event of the Mentoring and Coaching Programme
Collaborate your way to success
Health Education England Workforce Strategy - Key Points
Gestora brasileiro focada exclusivamente na área da saúde.
SCTR Scientific Retreat on Aging Related Research
A Centre for New Methods in Computational Diagnostics and Personalised Therapy This EU H2020 ‘Teaming for Excellence’ project develops a Business Case.
Finland, a Global Testbed for Personalized Cancer Research?
Opportunities to Pursue a Clinical and Translational Career at Penn Emma A. Meagher, MD Vice Dean for Clinical Research & Chief Clinical Research Officer.
Maximizing the value and the impact of health research in Europe
ACTSI Presentation to MSCR Coloquium
Jason Gerson, PhD Clinical Effectiveness and Decision Science
Johns Hopkins Medicine Innovation 2023 Strategic Plan
Health Education England Workforce Strategy - Key Points
What is “Biomedical Informatics”?
Funding Your Business From the moment the capital needed to start the activity is known, the following question arises: "Where to find it?" This is where.
Medical Research Funding and Regulation Third Annual Medical Research Summit March 6, 2003 Mary S. McCabe National Institutes of Health.
Dr. Lani (Chi Chi) Zimmerman, UNMC Dr. Bill Mahoney, IS&T
What is CICATS? The University of Connecticut, in partnership with regional hospitals, state agencies, and community health care organizations, has.
COMMERCILIZATION ISSUES AND CHALLANGES
Clinical and Translational Science Awards Program
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Research Issues & Projects Sadiq M. Sait
Re-Thinking Transportation for Individuals with Disabilities
Building PHN Scientists
Yelena Shevchenko Director of Strategic Planning and
The Nordics – a perfect setting for partnerships and investments
Elif KOŞOK TÜBİTAK TEYDEB Venture Capital Funding Group Executive Board Coordinator.
NUAcT Fellowship Scheme
Presentation transcript:

Translational Research: Case of Istanbul University Gamze Sart Istanbul University Translational Research: Case of Istanbul University

Translational research, “transforms scientific discoveries arising from the laboratory, clinical, or population studies into clinical applications…” Source: National Cancer Institute, National Institutes of Health

Istanbul University 23 Faculties +6,000 R&D 6 Hospitals 2,5 M Patients +400 Patents in 3 Years 10% registered

Translational potential • Does the proposed project address a high priority translational research area that challenges and seeks to shift current clinical practice paradigms by using novel assessment, preventive or therapeutic approaches or methodologies, instrumentation or intervention? • Is the proposed project based on a plan that is well- reasoned, realistic and feasible?

Translational potential • Have possible barriers been anticipated and are solutions and alternative strategies proposed? • Are all the needed resources, including drugs and reagents, readily available? • Are proposed expenses fully justified and reasonable in relation to the proposed project?

In Istanbul University, by using translational research strategies, specific subjects and treatments , such as breast cancer, have been transformed – developed, tested, and brought – into medical practice more rapidly.

New Tools & Applications Two Way Street Lab New Tools & Applications Clinic Population Source: National Cancer Institute

The Translation Continuum Basic Scientific Discovery Early Translation Late Translation Dissemination Adoption Promising gene Basic epidemiological finding Partnerships Intervention development Phase III trials Regulatory approval Health services research to support dissemination and adoption To community providers To patients and public Adoption of advance by providers, patients, and public Payment mechanisms to enable adoption Source: National Cancer Institute

The Istanbul University Roadmap Designed to provide the “bricks” of the homes of translational research Homes are academic centers with cadre of well-trained researchers Integrated resources (including informatics, upgraded biostatistics) Commitment to tearing down programmatic and disciplinary “silos” Flexible and individual – one size will not fit all

Our mission is to: Align organizational “service” based activities Provide education, training and mentoring to clinical research personnel Develop an integrated research infrastructure

Important Meta-cognitive Awareness Translation is not linear Penetration of the most successful interventions rarely exceeds 1% of target population Barriers to transfer Political atmosphere Public awareness Financing concerns Timing

Creation of a new intellectual discipline Strengths Designed to improve health Systems based approach proposed Multi-disciplinary Innovative Flexible and responsive to environment Collaborations within and outside of academic centers

Creation of a new intellectual discipline Potential barriers Institutional culture change Infusion of resources Infrastructure for funding, payments, tenure, institutional reviews Existing curricula for training scientists emphasis on independent research Shortage of mentors with skills

Scientific inquiry can limit translation Additional Problems Discovery of the solution is out of synch with providers “readiness to use it” Scientific inquiry can limit translation Costs of training and lag time until performance exceeds baseline

Investment Initiative Understand the translation of technology What makes a technology valuable / worth commercializing? What makes a good team? What makes a good company? Understand a critical component of the biomedical ecosystem Venture Creation Venture Capital Private Equity Hedge Funds Private Public

Entrepreneurship Initiative Our goal is to make the process of translating biotech and healthcare technologies at IU easier, faster, and more likely to succeed. Roadmap – Synthesis of all available resources at IU to assist healthcare entrepreneurs Survey – Inward and outward facing to determine greatest demand and need New Programming – Supplement the existing infrastructure in the areas of greatest need

Systematic Approach for Tech Valuation by Using 8Ms Machine Material Methodology Money Mother Earth BCC Mind Power Man Power Moments

Gamze Sart, Ph.D gamze.sart@istanbul.edu.tr +90532 296 8612